Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference57 articles.
1. Towards individualized therapy for metastatic renal cell carcinoma;Kotecha;Nat Rev Clin Oncol,2019
2. Renal cell carcinoma;Hsieh;Nat Rev Dis Primers,2017
3. Renal cell carcinoma;Jonasch;BMJ,2014
4. Targeted therapies for renal cell carcinoma;Posadas;Nat Rev Nephrol.,2017
5. The Immunobiology of kidney cancer;Drake;J Clin Oncol,2018
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma;Genes;2024-01-19
2. Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma;2024-01-12
3. Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study;Cancer Medicine;2023-10-30
4. Exploring the Cause of Survival Disparities in EGFR-mutated Lung Cancer Subtypes: Unraveling Distinctive Genomic and Phenotypic Features of 19Del and L858R Mutation Subtypes;2023-09-12
5. Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer;Medicine;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3